tirzepatide patent news Tirzepatide, the active ingredient behind the popular weight loss drug Zepbound and the diabetes drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders STUNNING: Lilly Could Lose Tirzepatide

Meanwhile, Eli Lilly is studying orforglipron in separate trials in patients with obstructive sleep apnea and hypertension

Also, some medications and diseases might increase the risk of the development of bruises in the patients. The good news is that injection site bruising usually isnt a big deal

Nat Reviews Bioeng

This may come in handy during treatment if a different name of the medication is used if the doctor is overlooking the patients treatment changes, or if one is purchasing the drug from a pharmacy and an alternative name of the medicine is used

Patients should drink water consistently throughout the day and maintain balanced electrolyte intake

The recent buzz surrounding the FDA's decision on BPC 157, a peptide renowned for its potential healing properties, has created quite a stir